Genesis IBRC Stock Screener | Share Price & Fundamental Analysis
GENESIS
Biotechnology
Share Price BSE
₹79.19
▲
3.74 (4.96%)
Track Genesis IBRC share price live with TickJournal's free stock screener.
Analyze Genesis IBRC share price history trends and compare 52-week high low
levels.
Calculate GENESIS stock fair value using fundamental analysis and view live share price charts.
Determine Genesis IBRC share intrinsic value and compare it with current GENESIS share price.
Record your Genesis IBRC trades in TickJournal's free trading journal and track your portfolio performance.
Genesis IBRC Market Cap
₹98.09 Cr.
Genesis IBRC P/B Ratio
11.99
EPS (TTM)
₹-0.03
Dividend Yield
-
Debt to Equity
0.15
GENESIS 52 Week High
₹184.90
Genesis IBRC 52 Week Low
₹18.34
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹12.00
Total Equity
₹10.00
Genesis IBRC Share Price History - Stock Screener Chart
Screen GENESIS historical share price movements with interactive charts. Analyze price trends and patterns.
Genesis IBRC Company Profile - Fundamental Screener
Screen Genesis IBRC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GENESIS shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE194N01016
Genesis IBRC Balance Sheet Screener
Screen GENESIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2018 |
|---|---|
| Assets | |
| Total Assets | 12 |
| Current Assets | 7 |
| Fixed Assets | 2 |
| Liabilities | |
| Total Liabilities | 0 |
| Current Liabilities | 0 |
| Non-Current Liabilities | 0 |
| Shareholders' Equity | |
| Total Equity | 10 |
| Share Capital | 13 |
| Reserves & Surplus | -3 |
Genesis IBRC Income Statement Screener - Profit & Revenue Analysis
Screen Genesis IBRC income statement and profit fundamentals.
Analyze GENESIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genesis IBRC share price evaluation.
| Item | None-None | 2018-March |
|---|---|---|
| Revenue | 0 | 4 |
| Expenses | 0 | 4 |
| EBITDA | 0 | 0 |
| Operating Profit % | 0.00% | 4.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 0 | 0 |
| Tax | 0 | 0 |
| Net Profit | 0 | 0 |
| EPS | 0.00 | -0.03 |
Genesis IBRC Cash Flow Screener - Liquidity Fundamentals
Screen GENESIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2018-March |
|---|---|
| Operating Activities | 2 |
| Investing Activities | -5 |
| Financing Activities | 3 |
| Net Cash Flow | 0 |
Genesis IBRC Shareholding Pattern Screener
See Genesis IBRC shareholding pattern with promoter, FII, and DII holdings.
Check Genesis IBRC promoter holding and ownership changes for GENESIS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.00% | 32.00% | 32.00% | 25.08% | 49.31% | 49.31% | 49.31% | 49.31% |
| Other Holding | 56.66% | 56.66% | 56.66% | 63.59% | 39.36% | 39.36% | 39.36% | 39.36% |
| Shareholder Count | 1,747 | 1,731 | 1,736 | 1,855 | 1,749 | 1,750 | 1,751 | 1,751 |
Genesis IBRC Share Dividend Screener - Share Yield Analysis
Check Genesis IBRC dividend history with payout and yield data.
View Genesis IBRC dividend details including ex-dates and amounts for GENESIS stock.
Genesis IBRC Stock Index Membership
See which indices include Genesis IBRC stock.
Check GENESIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genesis IBRC Market Events Screener - Corporate Actions
Get Genesis IBRC corporate actions including splits, bonuses, and buybacks.
Check Genesis IBRC stock events that may affect GENESIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.97% | ||
| Annual General Meeting | NA | 79.36% | ||
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -14.24% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 3.95% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 15.73% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 4.98% |
| 2018-01-12 | 2018-01-12 | Change Of Name | NA | - |
Genesis IBRC Competitors Screener - Peer Comparison
Screen GENESIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 39,383 | 81.44 | 1,930 | 30.15% | 451 | 63.83 |
| Advanced Enzyme Tech | 3,361 | 21.71 | 670 | 1.44% | 134 | 51.18 |
| Genesis IBRC | 98 | -427.78 | 4 | % | 0 | 46.54 |
| Vivo Bio Tech | 60 | 13.33 | 52 | 13.19% | 7 | 36.67 |
| Shree Ganesh Bio-Tech | 26 | -64.00 | 24 | 14.55% | 0 | 49.08 |
| Genomic Valley Biotech | 9 | -173.33 | 1 | 300.00% | 0 | 63.52 |
Genesis IBRC Company Announcements - News Screener
Screen GENESIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-14 | Results For The Quarter Ended On December 31 2025. | View |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 In Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2026-02-11 | Board Meeting Intimation for Approving Results For The Quarter Ended On December 31 2025 And Other Matters. | View |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-02 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Issue of Securities | View |
| 2026-01-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On 28-01-2026 | View |
| 2026-01-24 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-22 | Board Meeting Intimation for Board Meeting To Be Held On 28Th January 2026. | View |
| 2026-01-21 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-21 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-21 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Change of Company Name | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-01-19 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 19Th January 2026 | View |
| 2026-01-10 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |